Bone health assessment has long been centered around dual-energy X-ray absorptiometry (DXA), the gold standard for measuring bone mineral density (BMD). However, newer ultrasound-based technologies are emerging as valuable complementary—or in some cases alternative—tools, especially where DXA is not readily available.

Technologies such as Quantitative Ultrasound (QUS), Radiofrequency Echographic Multi Spectrometry (REMS), and Bindex are changing how clinicians evaluate bone density and fracture risk. These methods offer several advantages: they are radiation-free, portable, and cost-effective, while still providing meaningful information about bone quality and skeletal health.

How Ultrasound Differs from DXA

Unlike DXA, which uses ionizing radiation to directly measure bone mineral content, ultrasound-based systems assess how sound waves travel through and interact with bone tissue.

These interactions can reveal information about:

• Bone density
• Bone structure
• Bone elasticity
• Overall bone strength

While DXA primarily measures bone quantity, ultrasound methods may also provide insight into bone quality, an important factor in predicting fracture risk.

Quantitative Ultrasound (QUS)

QUS is one of the earliest and most widely used ultrasound methods for bone assessment. It is typically performed at peripheral skeletal sites, most commonly the calcaneus (heel bone).

QUS measures:

• Broadband Ultrasound Attenuation (BUA)
• Speed of Sound (SOS)

These values correlate with bone density and microarchitecture.

Advantages of QUS

• Portable and inexpensive
• Completely radiation-free
• Useful for large-scale osteoporosis screening
• Ideal for community settings or areas with limited DXA access

Limitations of QUS

• Measures peripheral rather than central sites (hip/spine)
• May not fully reflect fracture risk in clinically important areas
• Results can be affected by soft tissue, hydration, and positioning

Because of these limitations, QUS is generally used for screening and risk stratification, not as a standalone diagnostic test.

Radiofrequency Echographic Multi Spectrometry (REMS)

REMS is a more advanced ultrasound technology designed to overcome some limitations of traditional QUS.

It evaluates raw radiofrequency ultrasound signals collected from central skeletal sites, including:

• Lumbar spine
• Proximal femur

Rather than relying only on speed-of-sound measurements, REMS compares signal patterns to reference models of healthy and osteoporotic bone to estimate BMD more directly.

Advantages of REMS

• Evaluates central skeletal sites
• No ionizing radiation
• Useful for younger patients or those needing repeated monitoring
• Strong agreement with DXA in clinical studies

REMS may serve as an effective bridge between traditional ultrasound screening and DXA-level assessment.

Bindex

Bindex is a pulse-echo ultrasound device that measures cortical bone thickness, usually at the proximal tibia.

It works by sending ultrasound pulses into bone and analyzing reflected signals. This information is then combined with clinical risk factors to estimate the likelihood of osteoporosis.

Advantages of Bindex

• Effective triage tool
• Helps determine whether DXA is needed
• Can reduce unnecessary referrals
• Improves efficiency and lowers healthcare costs

Limitations

• Does not directly measure central-site BMD
• Best used as part of a broader clinical assessment

Comparing the Technologies

Each ultrasound method fills a different role in bone health assessment:

Together, these tools broaden access to bone health evaluation beyond traditional methods.

Why This Matters for Clinicians and Educators

As healthcare shifts toward more accessible and patient-centered care, ultrasound-based bone assessment offers important flexibility.

These technologies may support:

• Earlier detection of osteoporosis
• Expanded screening access
• More frequent monitoring
• Reduced radiation exposure
• Better use of DXA resources

For professionals in bone densitometry and osteoporosis management, understanding QUS, REMS, and Bindex is becoming increasingly valuable.

The Future of Bone Density Assessment

DXA remains the gold standard, but emerging ultrasound technologies are not replacements—they are complementary tools that help fill gaps in care.

The future is likely multimodal, combining:

• The precision of DXA
• The accessibility of ultrasound
• Smarter screening pathways
• Improved fracture prevention strategies

This integrated approach has the potential to improve early detection and reduce the global burden of osteoporotic fractures.